Blog

Susan Slaugenhaupt, PhD, is the Scientific Director of the Mass General Research Institute and an Investigator in the Center for Genomic Medicine.

President-elect Joe Biden held a press conference to announce a team of health experts, including Dr. Rochelle Walensky, who was appointed to be the new Director for the Center for Disease Control and Prevention.

After news broke that Mass General’s Rochelle Walensky, MD, MPH, was tapped for CDC director, friends and colleagues voiced their support on Twitter.

CAR T cell therapy is a promising form of treatment for cancer, and now Ragon Institute investigator Todd Allen, PhD, recently published findings suggesting dual CAR T cell therapy could be an option for HIV.

A unique platform developed in anticipation of a rapidly spreading infectious disease like COVID-19 is now being put into action to develop a vaccine.

Mass General researchers have made a key discovery about how the cellular process of autophagy can extend or shorten lifespan.

The second annual Mass General Research Institute LAB DAY gave friends and supporters of Mass General research an up-close look at science.

To understand more about infant immunity and how to enhance it, a research team led by Galit Alter, PhD investigated how certain antibodies are transferred from mother to child during pregnancy.

Mass General researchers have created a new zebrafish model that could vastly improve our ability to model cancer growth and test new treatments.

Researchers at the Center for Genomic Medicine have become pivotal players in the emergence of precision medicine due to their various roles as local and international leaders in genomics.